214 related articles for article (PubMed ID: 7846939)
1. [Sotalol and quinidine/verapamil (Cordichin) in chronic atrial fibrillation--conversion and 12-month follow-up--a randomized comparison].
Kalusche D; Stockinger J; Betz P; Roskamm H
Z Kardiol; 1994; 83 Suppl 5():109-16. PubMed ID: 7846939
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and proarrhythmic hazards of pharmacologic cardioversion of atrial fibrillation: prospective comparison of sotalol versus quinidine.
Hohnloser SH; van de Loo A; Baedeker F
J Am Coll Cardiol; 1995 Oct; 26(4):852-8. PubMed ID: 7560608
[TBL] [Abstract][Full Text] [Related]
3. [Amiodarone and verapamil/quinidine in treatment of patients with chronic atrial fibrillation].
Zehender M; Meinertz T; Just H
Z Kardiol; 1994; 83 Suppl 5():101-8. PubMed ID: 7846938
[TBL] [Abstract][Full Text] [Related]
4. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
Trappe HJ; Pfitzner P
Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
[TBL] [Abstract][Full Text] [Related]
5. Atrial fibrillation: rate control often better than rhythm control.
Prescrire Int; 2004 Apr; 13(70):64-9. PubMed ID: 15148984
[TBL] [Abstract][Full Text] [Related]
6. Suppression of paroxysmal atrial tachyarrhythmias--results of the SOPAT trial.
Patten M; Maas R; Bauer P; Lüderitz B; Sonntag F; Dluzniewski M; Hatala R; Opolski G; Müller HW; Meinertz T;
Eur Heart J; 2004 Aug; 25(16):1395-404. PubMed ID: 15321697
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of atrial fibrillation in a Hungarian hospital department of cardiologic internal medicine at the turn of the millennium].
Márk L; Erdej F; Dani G; Borbély M; Sziklai G; Nagy E; Hajdara I; Katona A
Orv Hetil; 2004 May; 145(19):1001-6. PubMed ID: 15181735
[TBL] [Abstract][Full Text] [Related]
8. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
Fetsch T; Bauer P; Engberding R; Koch HP; Lukl J; Meinertz T; Oeff M; Seipel L; Trappe HJ; Treese N; Breithardt G;
Eur Heart J; 2004 Aug; 25(16):1385-94. PubMed ID: 15302102
[TBL] [Abstract][Full Text] [Related]
9. [Effects of amiodarone versus sotalol in treatment of atrial fibrillation: a random controlled clinical study].
Niu F; Huang CX; Jiang H; Yang B; Guo WL; Chen YX; Jin CR; Liu ZM
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):121-3. PubMed ID: 16620720
[TBL] [Abstract][Full Text] [Related]
10. [Therapy of atrial fibrillation with class III anti-arrhythmia agents].
Follath F; Candinas R; Frielingsdorf J
Herz; 1993 Feb; 18(1):20-6. PubMed ID: 8454249
[TBL] [Abstract][Full Text] [Related]
11. [Combination of quinidine and verapamil in auricular fibrillation].
Sobrino JA; Maté I; Calvo L; Plaza I; Rico J; Moreno I; Mesa JM
Rev Esp Cardiol; 1989 Apr; 42(4):262-6. PubMed ID: 2781120
[TBL] [Abstract][Full Text] [Related]
12. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
[TBL] [Abstract][Full Text] [Related]
13. [Combination treatment of atrial arrhythmias with quinidine-verapamil].
Gülker H; Bramann HU; Brisse B; Kuhs H
Med Klin; 1980 Feb; 75(5):196-8. PubMed ID: 6156393
[TBL] [Abstract][Full Text] [Related]
14. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
Plewan A; Lehmann G; Ndrepepa G; Schreieck J; Alt EU; Schömig A; Schmitt C
Eur Heart J; 2001 Aug; 22(16):1504-10. PubMed ID: 11482924
[TBL] [Abstract][Full Text] [Related]
15. [Medicamentous prevention after electric cardioversion of chronic atrial fibrillation. Goals and design of the PAFAC Study].
Fetsch T; Burschel G; Breithardt G; Engberding R; Koch HP; Lukl J; Trappe HJ; Treese N
Z Kardiol; 1999 Mar; 88(3):195-207. PubMed ID: 10355070
[TBL] [Abstract][Full Text] [Related]
16. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
Frick M; Darpö B; Ostergren J; Rosenqvist M
Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
[TBL] [Abstract][Full Text] [Related]
17. Aggravation of postcardioversion atrial dysfunction by sotalol.
Pollak A; Falk RH
J Am Coll Cardiol; 1995 Mar; 25(3):665-71. PubMed ID: 7860911
[TBL] [Abstract][Full Text] [Related]
18. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
Naegeli B; Straumann E; Bertel O
Int J Cardiol; 2005 Mar; 99(2):283-7. PubMed ID: 15749188
[TBL] [Abstract][Full Text] [Related]
19. [Pharmacologic restoration of sinus rhythm in atrial flutter and fibrillation].
Vainer J; Smíd J; Cepeláková H; Hapala J; Topinka I; Topolcan O
Vnitr Lek; 1989 Feb; 35(2):145-50. PubMed ID: 2711622
[TBL] [Abstract][Full Text] [Related]
20. A prospective, randomized controlled trial comparing the efficacy and safety of sotalol, amiodarone, and digoxin for the reversion of new-onset atrial fibrillation.
Joseph AP; Ward MR
Ann Emerg Med; 2000 Jul; 36(1):1-9. PubMed ID: 10874228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]